Integration of safe initial combination chemotherapy (without cisplatin) with a high response rate and local therapy for untreated stage III and IV epidermoid cancer of the head and neck: 5-year survival data.

MLA

Price, L. A., et al. “Integration of Safe Initial Combination Chemotherapy (without Cisplatin) with a High Response Rate and Local Therapy for Untreated Stage III and IV Epidermoid Cancer of the Head and Neck: 5-Year Survival Data.” Cancer Treatment Reports, vol. 67, no. 6, June 1983, pp. 535–39. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=6190557&authtype=sso&custid=ns315887.

APA

Price, L. A., MacRae, K., & Hill, B. T. (1983). Integration of safe initial combination chemotherapy (without cisplatin) with a high response rate and local therapy for untreated stage III and IV epidermoid cancer of the head and neck: 5-year survival data. Cancer Treatment Reports, 67(6), 535–539.

Chicago

Price, L A, K MacRae, and B T Hill. 1983. “Integration of Safe Initial Combination Chemotherapy (without Cisplatin) with a High Response Rate and Local Therapy for Untreated Stage III and IV Epidermoid Cancer of the Head and Neck: 5-Year Survival Data.” Cancer Treatment Reports 67 (6): 535–39. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=6190557&authtype=sso&custid=ns315887.